(Reuters) – Europe’s drug regulator on Thursday recommended addition of a rare type of spinal inflammation as a side-effect of Johnson & Johnson’s COVID-19 vaccine.
It was also assessing reports of capillary leak syndrome following inoculation with Moderna’s shot.
The European Medicines Agency said currently there was not enough evidence of a possible link between rare cases of multisystem inflammatory syndrome with mRNA vaccines, including Moderna’s shot.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Arun Koyyur)
